tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market

Enanta Pharmaceuticals (ENTA) Income Statement

Compare
175 Followers

Enanta Pharmaceuticals Income Statement

Last quarter (Q1 2025), Enanta Pharmaceuticals's total revenue was $16.96M, a decrease of -5.80% from the same quarter last year. In Q1, Enanta Pharmaceuticals's net income was $-22.29M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 67.64M$ 79.20M$ 86.16M$ 97.07M$ 122.47M
Gross Profit
$ 67.64M$ 79.20M$ 83.19M$ 97.07M$ 122.47M
Operating Expenses
$ 189.33M$ 216.41M$ 210.00M$ 206.65M$ 164.11M
Depreciation and Amortization
$ 2.34M$ 2.37M$ 2.97M$ 3.33M$ 3.64M
EBITDA
$ -104.51M$ -123.48M$ -119.22M$ -104.25M$ -37.99M
Operating Income
$ -121.69M$ -137.21M$ -123.84M$ -109.57M$ -41.64M
Other Income/Expenses
$ 3.90M$ 6.21M$ 1.66M$ 1.99M$ 6.62M
Pretax Income
$ -117.79M$ -131.00M$ -122.19M$ -107.58M$ -35.02M
Net Income
$ -116.05M$ -133.82M$ -121.75M$ -79.00M$ -36.17M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.48$ -6.38$ -5.91$ -3.92$ -1.81
Diluted EPS
$ -5.48$ -6.38$ -5.91$ -3.92$ -1.81
Weighted Average Shares Outstanding
21.16M 20.97M 20.60M 20.17M 19.94M
Weighted Average Shares Outstanding (Diluted)
21.16M 20.97M 20.60M 20.17M 19.94M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis